Last updated on November 2015

E2112 A Randomized Phase III Trial of Endocrine Therapy plus Entinostat/Placebo in Postmenopausal Patients with Hormone Receptor-Positive Advanced Breast Cancer


Brief description of study

E2112 A Randomized Phase III Trial of Endocrine Therapy plus Entinostat/Placebo in Postmenopausal Patients with Hormone Receptor-Positive Advanced Breast Cancer

Detailed Study Description

The purpose of this study is find out what effects, both good and/or bad, entinostat has on HER2-locally advanced or metastatic breast cancer, when given together with the standard hormonal drug treatment, exemestane.

Clinical Study Identifier: TX141821

Find a site near you

Start Over

AMITA Health

3040 Salt Creek Lane Arlington Heights, IL USA
  Connect »